课题基金 / 基金详情

University of Washington Stipends for Training Aspiring Researchers (STAR) Program

University of Washington Stipends for Training Aspiring Researchers (STAR) Program
华盛顿大学培训有抱负的研究人员(STAR)计划的津贴
批准号:
10260195
负责人:
Michael A Portman
金额:
$9.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
未结题
起止时间:
2010-06-01 至 2026-08-31

项目摘要

项目成果

Michael A Portman的其他基金

相似基金

相关文献

中文摘要
翻译
2021-2026 UW STAR计划-项目摘要 STAR计划在2019年完成了其第九年的资助,占计划的91% 参与者注册或完成生物医学研究生或健康专业学位。 该方案在有效培训任职人数不足方面发挥了不可或缺的作用。 少数民族,第一代,经济困难的学生,追求健康, 生物医学和生物行为研究途径。该计划的长远目标 该计划的未来五年是扩大其倡议,从71%增加到80% 参加人数,进入和完成生物医学和行为学专业以及 最终被专业/研究生课程录取。为了实现这一目标, UW STAR计划团队建议将一系列扩展的活动和 由教职员工组成的协作团队来实施其倡议。同时继续 加强学生的学术和技术技能,该计划还将重点帮助 参与者了解心脏、肺和血液相关研究的作用,以及 这项研究在解决代表不足人群健康差距方面的后续影响 社区。华盛顿大学明星计划的总体目标 是开发创新的节目,以提供代表不足的少数群体(URM) 学生,第一代学生,经济和教育上的弱势群体 学生和/或残疾学生具有概念基础和 支持他们攻读本科后课程目标的实验室经验 获得医学博士、医学博士、博士和硕士学位。为了实现这一目标,明星 课程将由四(4)个主要部分组成:教学实验室:为期10周的课程 将介绍正在崛起的大二和大三学生,没有任何正式的 生物医学/行为实验室经验,以及所需的基本技术 和研究方法。研究实验室部分将为二年级学生提供 通过未毕业的大四/一年级毕业生/上升的二年级医科学生学习10年 几周,在华盛顿大学教职员工的指导下体验实验室 以NHLBI为重点的研究。保留活动,让参与者保持兴奋 通过研究人员主导的讲座以NHLBI为重点的研究;鼓励参与 在学生所在机构使用技能的学年实验室经验 从教学实验室学习到的知识;以及项目人员持续提供的整体建议。最后,一个 年度评估,将导致计划活动的微调/细化,基于 参与者反馈。
英文摘要
2021 – 2026 UW STAR PROGRAM – PROJECT SUMMARY ABSTRACT The STAR Program completed its ninth year of funding in 2019 with 91% of program participants enrolled in or completed biomedical graduate or health professional degrees. The program has been an integral contributor in effectively training underrepresented minority, first generation, and economically disadvantaged, students to pursue health, biomedical, and biobehavioral research pathways. The long-term objective of the Program’s next five years is to expand its initiatives to increase from 71% to 80% the number of participants, entering and completing biomedical and behavioral majors and eventually matriculating into professional/graduate programs. To fulfill this objective, the UW STAR Program team proposes to bring together an expanded set of activities and a collaborative team of faculty and staff to implement its initiative. While continuing to strengthen students’ academic and technical skills, the Program will also focus on helping participants understand the role of heart, lung, and blood-related research and the subsequent impact of this research in addressing health disparities in underrepresented communities. The overarching objective of the University of Washington STAR Program is to develop innovative programming that will provide underrepresented minority (URM) students, first generation students, economically and educationally disadvantaged students, and/or students with disabilities with the conceptual underpinnings and laboratory experiences that support their goals of pursuing post-undergraduate studies leading to MD, MD/PhD, PhD, and Masters’ degrees. To fulfill this objective, the STAR Program will consist of four (4) major components: Teach Lab: a 10 week program that will introduce rising sophomore and junior level students, without any formal biomedical/behavioral laboratory experience, to the required, fundamental techniques and methods of research. The Research Laboratory component will place sophomore through non-graduating senior/1st year graduate/rising 2nd year medical students for 10 weeks, in mentored laboratory experiences with University of Washington staff involved in NHLBI-focused research. Retention Activities to keep participants excited about NHLBI-focused research through researcher-led lectures; encouraging participation in academic-year laboratory experiences at students’ respective institutions using skills learned in Teach Lab; and, on-going, holistic advising by program staff. And finally, an annual Evaluation that will lead to fine-tuning/refinement of Program activities, based on participant feedback.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Prediction for Treatment Resistance in Kawasaki Disease
  • 批准号:
    10311527
  • 项目类别:
  • 资助金额:
    $87.05万
  • 财政年份:
    2018
  • 负责人:
    Michael A Portman
  • 依托单位:
Genetic Prediction for Treatment Resistance in Kawasaki Disease
  • 批准号:
    10065014
  • 项目类别:
  • 资助金额:
    $84.7万
  • 财政年份:
    2018
  • 负责人:
    Michael A Portman
  • 依托单位:
Genetic Prediction for Treatment Resistance in Kawasaki Disease
  • 批准号:
    10517919
  • 项目类别:
  • 资助金额:
    $10.7万
  • 财政年份:
    2018
  • 负责人:
    Michael A Portman
  • 依托单位:
Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass
  • 批准号:
    8610834
  • 项目类别:
  • 资助金额:
    $40.0万
  • 财政年份:
    2014
  • 负责人:
    Michael A Portman
  • 依托单位:
海外基金